ABEO

Abeona Therapeutics Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-17

Figures on this page computed 2026-11-08 12:55 UTC

Last close

3.91USD

Market data, 2026-11-05

ABEO: weekly closes from 4.20 on 2025-11-07 to 3.91 on 2026-11-05, a move of -6.9%. Prices in USD.

Weekly closes, 2025-11-07 to 2026-11-05

Over that span: -6.9%

Except where said otherwise: 10-K for 2025, filed 2026-03-17

3.1xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-17
The filing itself
-84.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-17
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/mNet marginnet income exceeds revenue
Net income exceeds revenue.
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
The filing itself
-1448.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
The filing itself
0.16Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Margins is the furthest below its sector's middle: 0.32 against 0.41 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.64x

-1.63x

1.74x

1.04x

0.05x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-05

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-17

Sales1.64x
Its own average over 8 years, 3.6M.
Profit-1.63x
Its own average over 10 years, -43.8M.
Free cash flow1.74x
Its own average over 10 years, -48.4M.
Debt1.04x
Its own average over 2 years, 24.0M.
Price0.05x
Its own average over 11 years, 86. Market data, 2026-11-05

Profit is furthest from its own average, at -1.63 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2016-12-31	100.0	100.0
2017-12-31	94.2	n/a
2018-12-31	337.2	n/a
2020-12-31	1,124.9	n/a
2021-12-31	337.5	288.0
2022-12-31	159.1	575.0
2023-12-31	393.7	1,563.8
2024-12-31	n/a	3,002.3
2025-12-31	654.7	4,837.3

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001493152-26-010413
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001493152-26-010413
Reported in: USD

The filing itself

Figures behind the shape

Growth

-10.3%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate-10.3%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income211.7%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

-84.5%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capital-84.5%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-17
- 10-Q for 2025, filed 2026-08-13
The filing itself
Return on equity44.7%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-Q for 2025, filed 2026-08-13
The filing itself
Return on assets32.4%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-Q for 2025, filed 2026-08-13
The filing itself

Margins

73.7%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin73.7%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
The filing itself
Operating margin-1536.9%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
The filing itself
Net marginn/mnet income exceeds revenue
Net income exceeds revenue.
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
The filing itself
Free cash flow margin-1448.5%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
The filing itself

Price

3.1x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earnings3.1x
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-17
The filing itself
Price to book1.7x10-Q for 2025, filed 2026-08-13
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001493152-26-037576
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-08-13
- computed
- 10-K for 2025, filed 2026-03-17
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-17
The filing itself
Price to sales ratio47.4x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
The filing itself

Safety

0.16

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.16
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-Q for 2025, filed 2026-08-13
The filing itself
Current ratio6.9310-Q for 2025, filed 2026-08-13
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001493152-26-037576
Reported in
USD
- 10-Q for 2025, filed 2026-08-13
- 10-Q for 2025, filed 2026-08-13
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
The filing itself
Altman Z-Score-2.35
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-03-17
- Computed from the 10-K for 2025, filed 2026-03-17
- Computed from the 10-K for 2025, filed 2026-03-17
- Computed from the 10-K for 2025, filed 2026-03-17
- Computed from the 10-K for 2025, filed 2026-03-17

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001493152-26-010413
Reported in
USD
- 10-K for 2025, filed 2026-03-17
- Computed from the 10-K for 2025, filed 2026-03-17
- 10-K for 2025, filed 2026-03-17
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.